Globus Medical Return on Tangible Equity 2010-2024 | GMED
Current and historical return on tangible equity values for Globus Medical (GMED) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Globus Medical Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-12-31 | $0.10B | $1.95B | 5.96% |
| 2024-09-30 | $0.09B | $1.80B | 5.51% |
| 2024-06-30 | $0.04B | $1.66B | 2.45% |
| 2024-03-31 | $0.07B | $1.58B | 3.97% |
| 2023-12-31 | $0.12B | $1.64B | 7.20% |
| 2023-09-30 | $0.16B | $1.80B | 9.33% |
| 2023-06-30 | $0.20B | $1.73B | 12.55% |
| 2023-03-31 | $0.20B | $1.66B | 12.91% |
| 2022-12-31 | $0.19B | $1.59B | 12.43% |
| 2022-09-30 | $0.16B | $1.53B | 10.30% |
| 2022-06-30 | $0.16B | $1.46B | 10.38% |
| 2022-03-31 | $0.14B | $1.54B | 9.59% |
| 2021-12-31 | $0.15B | $1.49B | 10.45% |
| 2021-09-30 | $0.19B | $1.48B | 13.66% |
| 2021-06-30 | $0.18B | $1.41B | 14.15% |
| 2021-03-31 | $0.12B | $1.33B | 9.84% |
| 2020-12-31 | $0.10B | $1.26B | 8.61% |
| 2020-09-30 | $0.10B | $1.21B | 8.14% |
| 2020-06-30 | $0.09B | $1.12B | 7.75% |
| 2020-03-31 | $0.15B | $1.15B | 13.04% |
| 2019-12-31 | $0.16B | $1.20B | 14.01% |
| 2019-09-30 | $0.15B | $1.13B | 13.89% |
| 2019-06-30 | $0.14B | $1.07B | 14.29% |
| 2019-03-31 | $0.15B | $1.03B | 15.67% |
| 2018-12-31 | $0.16B | $0.97B | 17.33% |
| 2018-09-30 | $0.14B | $0.93B | 16.87% |
| 2018-06-30 | $0.14B | $0.90B | 16.80% |
| 2018-03-31 | $0.12B | $0.82B | 15.77% |
| 2017-12-31 | $0.11B | $0.77B | 14.92% |
| 2017-09-30 | $0.11B | $0.73B | 15.46% |
| 2017-06-30 | $0.11B | $0.70B | 16.01% |
| 2017-03-31 | $0.11B | $0.70B | 15.84% |
| 2016-12-31 | $0.10B | $0.66B | 16.16% |
| 2016-09-30 | $0.12B | $0.63B | 18.87% |
| 2016-06-30 | $0.12B | $0.66B | 19.53% |
| 2016-03-31 | $0.12B | $0.62B | 20.37% |
| 2015-12-31 | $0.11B | $0.59B | 21.12% |
| 2015-09-30 | $0.10B | $0.55B | 20.12% |
| 2015-06-30 | $0.10B | $0.52B | 19.94% |
| 2015-03-31 | $0.10B | $0.49B | 19.69% |
| 2014-12-31 | $0.09B | $0.50B | 19.19% |
| 2014-09-30 | $0.09B | $0.51B | 18.45% |
| 2014-06-30 | $0.08B | $0.48B | 18.62% |
| 2014-03-31 | $0.07B | $0.45B | 16.24% |
| 2013-12-31 | $0.07B | $0.42B | 16.71% |
| 2013-09-30 | $0.07B | $0.42B | 17.37% |
| 2013-06-30 | $0.06B | $0.40B | 17.29% |
| 2013-03-31 | $0.08B | $0.38B | 21.89% |
| 2012-12-31 | $0.07B | $0.36B | 22.95% |
| 2012-09-30 | $0.07B | $0.34B | 22.46% |
| 2012-06-30 | $0.07B | $0.31B | 31.85% |
| 2012-03-31 | $0.06B | $0.28B | 45.17% |
| 2011-12-31 | $0.06B | $0.27B | 84.53% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.891B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $189.754B | 83.11 |
| Thermo Fisher Scientific (TMO) | United States | $159.887B | 19.34 |
| Alcon (ALC) | Switzerland | $48.486B | 32.23 |
| Edwards Lifesciences (EW) | United States | $44.472B | 29.10 |
| IDEXX Laboratories (IDXX) | United States | $37.951B | 43.61 |
| DexCom (DXCM) | United States | $32.004B | 49.47 |
| IQVIA Holdings (IQV) | United States | $27.061B | 14.97 |
| Mettler-Toledo (MTD) | United States | $22.925B | 27.19 |
| STERIS (STE) | Ireland | $22.088B | 25.26 |
| Waters (WAT) | United States | $20.850B | 29.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.568B | 0.00 |
| Hologic (HOLX) | United States | $12.153B | 13.11 |
| Sysmex ADR (SSMXY) | Japan | $11.545B | 0.00 |
| Penumbra (PEN) | United States | $11.463B | 89.97 |
| Masimo (MASI) | United States | $8.993B | 37.74 |
| Teleflex (TFX) | United States | $5.586B | 9.22 |
| Glaukos (GKOS) | United States | $5.006B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.385B | 22.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.077B | 0.00 |
| TransMedics (TMDX) | United States | $3.044B | 89.09 |
| Veracyte (VCYT) | United States | $2.377B | 42.75 |
| Nihon Kohden (NHNKY) | Japan | $2.113B | 11.55 |
| LivaNova (LIVN) | United Kingdom | $2.005B | 12.14 |
| Elekta AB (EKTAY) | Sweden | $1.960B | 17.62 |
| Alphatec Holdings (ATEC) | United States | $1.754B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.431B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.302B | 6.58 |
| Pulse Biosciences (PLSE) | United States | $1.156B | 0.00 |
| OPKO Health (OPK) | United States | $1.098B | 0.00 |
| Artivion (AORT) | United States | $0.996B | 93.32 |
| AxoGen (AXGN) | United States | $0.780B | 0.00 |
| IRadimed (IRMD) | United States | $0.680B | 35.65 |
| Mesa Laboratories (MLAB) | United States | $0.647B | 14.14 |
| RxSight (RXST) | United States | $0.644B | 0.00 |
| SiBone (SIBN) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.565B | 9.10 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.513B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.457B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.415B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.36 |
| Pacific Biosciences Of California (PACB) | United States | $0.339B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.333B | 17.82 |
| Neuronetics (STIM) | United States | $0.301B | 0.00 |
| CVRx (CVRX) | United States | $0.207B | 0.00 |
| 908 Devices (MASS) | United States | $0.200B | 0.00 |
| Inogen (INGN) | United States | $0.194B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.183B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.160B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.158B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 10.82 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.32 |